Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-106
Closed -$46K 499
2022
Q3
$46K Hold
106
﹤0.01% 527
2022
Q2
$50K Hold
106
﹤0.01% 513
2022
Q1
$54K Hold
106
﹤0.01% 510
2021
Q4
$56K Hold
106
﹤0.01% 511
2021
Q3
$49K Hold
106
﹤0.01% 505
2021
Q2
$50K Hold
106
﹤0.01% 525
2021
Q1
$49K Hold
106
﹤0.01% 455
2020
Q4
$56K Buy
+106
New +$52.1K ﹤0.01% 363
2020
Q1
Sell
-6
Closed -$2.64K 1167
2019
Q4
$2.64K Hold
6
﹤0.01% 1031
2019
Q3
$2.5K Buy
+6
New +$2.45K ﹤0.01% 1163

Other funds holding CHE

Evoke Wealth's CHE Position: Q4 2022 in Review

Evoke Wealth sold out of Chemed (CHE) in Q4 2022, closing a stake of 106 shares — an estimated $46K sold.

Evoke Wealth first reported a position in CHE in Q3 2019 and held it in 10 quarters. The position peaked at $56K in Q4 2021. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2022.

  • Evoke Wealth reported no remaining Chemed position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 106 Chemed shares in Q4 2022, an estimated $46K.
  • Evoke Wealth first reported a position in Chemed in Q3 2019 and held it in 10 quarters.
  • Evoke Wealth's Chemed position peaked at $56K in Q4 2021.
  • 442 funds tracked by Wall St. Rank held Chemed as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.